Almost half of women taking GLP-1s say they are more interested in beauty than they were a year ago, according to analyst Sydney Wagner. Continue Reading
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
Weight-Loss Drugs Are Fueling a Beauty Boom. Two Stocks That Stand to Benefit.
